Enhabit reported Q4 2025 net service revenue of USD 270.4 million (up 4.7%), with a net loss attributable to shareholders of USD 38.7 million and a diluted loss per share of USD 0.76. Adjusted EBITDA was USD 28.0 million (up 11.6%) with an Adjusted EBITDA margin of 10.4%, while adjusted diluted EPS was USD 0.14. In home health, Q4 net service revenue was USD 206.8 million (up 3.2%), supported by total admissions of 56,778 (up 7.3%) and average daily census of 42,324 (up 6.4%); cost per patient day decreased 3.5%. In hospice, Q4 net service revenue was USD 63.6 million (up 10.0%), with average daily census of 4,099 (up 9.9%) and Segment Adjusted EBITDA of USD 13.6 million (up 2.3%). The company highlighted a definitive agreement to be acquired by Kinderhook Industries for USD 13.80 per share in cash (enterprise value of approximately USD 1.1 billion), with closing expected in Q2 2026 subject to approvals. Enhabit also entered into an amended and restated credit agreement on Feb. 26, 2026, extending maturity to February 2031, and said it opened four de novo locations in Q4 2025 (10 in 2025) and made its eighth straight quarter of debt prepayment, including an additional USD 20.0 million prepayment in Q1 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enhabit Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260303111104) on March 04, 2026, and is solely responsible for the information contained therein.